Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...

Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...

Caroline Banton has 6+ years of experience as a writer of business and finance articles. She also writes biographies for Story Terrace. Suzanne is a content marketer, writer, and fact-checker. She ...

Learn to simulate stock prices with Excel and gain predictive power over market trends. Our step-by-step guide enhances your ...

Analysis suggests consumption at Northumberland site could be 50 times higher than US operator QTS estimates The UK’s largest proposed datacentre is understating the scale of its planned water use, ...

IMF Quota and Governance Reform—Elements of an Agreement (October 31, 2010) Fourteenth General Review of Quotas—Possible Elements of a Compromise, Additional Simulations, and The Chairman's Concluding ...

Historical Data is currently not available. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.